ProCE Banner Series

2023 PCE Oncology Fall Conferences

Join us for two complimentary CE/CME meetings tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Each date offers a unique agenda, with the first focused on hematologic malignancies and the second on solid tumors.  Earn up to 7 credits! 

Register now for both meetings and maximize your credits! 

  AAPA
  | ANCC
Credits Available

1.0 Per Topic

Who Should Attend

Oncology NPs, PAs, and RNs 

All Events

2023 PCE Oncology Fall Conferences

Upcoming Events

October

14

2023

ProCE Banner

8:00 AM - 6:10 PM Eastern Time (ET)

Virtual

CE / CME

October

28

2023

ProCE Banner

9:00 AM - 7:10 PM Eastern Time (ET)

Virtual

CE / CME

Topics

Topics include*:
CLL/SLL and MCL
Diffuse Large B-Cell Lymphoma
Multiple Myeloma
Breast Cancer
Gastric Cancer
Melanoma
Non-small cell lung cancer

*Different topics per date

CME/CE Info

Program Overview
This live webinar program is designed for nurse practitioners, physician associates, and nurses who practice in oncology and will provide accredited education covering timely, expert-led, evidence-based education across a range of different cancers to advance the care of patients with cancer.

Target Audience
Oncology NPs, PAs, and RNs

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Evaluate the latest evidence in the treatment of cancer including recommended biomarker testing, safety and efficacy of available therapies, and strategies to address health disparities
  • Integrate evidence-based strategies into practice for managing and individualizing the care of patients with cancer
  • Assess toxicities associated with treatments for cancer and apply recommended management strategies

Accreditation

Per Topic

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

  • Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL: 1.0

Physician Associate Continuing Medical Education

Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

    • Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL: 1.0

IPCE Credit Designation

 

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

  • Recent Progress with CD38 Antibodies to Improve Outcomes in Multiple Myeloma: Expert Guidance for Clinical Practice: 1.0

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

  • Recent Progress with CD38 Antibodies to Improve Outcomes in Multiple Myeloma: Expert Guidance for Clinical Practice: 1.0

Continuing Pharmacy Education

**CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-227-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

  • Recent Progress with CD38 Antibodies to Improve Outcomes in Multiple Myeloma: Expert Guidance for Clinical Practice: 1.0

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) and Partners for Advancing Clinical Education (PACE) require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO and PACE policy. CCO and PACE are committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and Rockpointe. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

USF Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For information about accreditation of this activity, please email: cpdsupport@usf.edu 

  • Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes with Novel Approaches to Targeted Therapy: 1.0

ABIM MOC RECOGNITION STATEMENT

Successful completion of the CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is USF Health’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes with Novel Approaches to Targeted Therapy: 1.0

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through USF Health’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

Participants will earn MOC Points equivalent to the amount of CME credits claimed for the activity. USF Health will submit within 60 days the Participant’s MOC Points. No MOC certificates will be provided. Participants with questions regarding their Points, should contact USF Health at cpdsupport@usf.edu.

Relevant Financial Relationships Disclosures:
USF Health and Rockpointe adhere to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. Prior to the activity, USF Health will disclose and mitigate all relevant financial relationships that relate to the content of the activity.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE) and Clinical Care Options, LLC